Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 2
2013 1
2014 4
2015 8
2016 4
2017 1
2019 2
2020 3
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Determinants of malaria testing at health facilities: the case of Uganda.
Kigozi RN, Bwanika J, Goodwin E, Thomas P, Bukoma P, Nabyonga P, Isabirye F, Oboth P, Kyozira C, Niang M, Belay K, Sebikaari G, Tibenderana JK, Gudoi SS. Kigozi RN, et al. Malar J. 2021 Dec 4;20(1):456. doi: 10.1186/s12936-021-03992-9. Malar J. 2021. PMID: 34863172 Free PMC article.
Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.
Yeka A, Wallender E, Mulebeke R, Kibuuka A, Kigozi R, Bosco A, Kyambadde P, Opigo J, Kalyesubula S, Senzoga J, Vinden J, Conrad M, Rosenthal PJ. Yeka A, et al. Among authors: kigozi r. J Infect Dis. 2019 Mar 15;219(7):1112-1120. doi: 10.1093/infdis/jiy637. J Infect Dis. 2019. PMID: 30418593 Free PMC article. Clinical Trial.
Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.
Ebong C, Sserwanga A, Namuganga JF, Kapisi J, Mpimbaza A, Gonahasa S, Asua V, Gudoi S, Kigozi R, Tibenderana J, Bwanika JB, Bosco A, Rubahika D, Kyabayinze D, Opigo J, Rutazana D, Sebikaari G, Belay K, Niang M, Halsey ES, Moriarty LF, Lucchi NW, Souza SSS, Nsobya SL, Kamya MR, Yeka A. Ebong C, et al. Among authors: kigozi r. Malar J. 2022 Feb 7;21(1):37. doi: 10.1186/s12936-022-04049-1. Malar J. 2022. PMID: 35130919 Free PMC article. No abstract available.
Practical Implications of a Relationship between Health Management Information System and Community Cohort-Based Malaria Incidence Rates.
Kigozi SP, Giorgi E, Mpimbaza A, Kigozi RN, Bousema T, Arinaitwe E, Nankabirwa JI, Sebuguzi CM, Kamya MR, Staedke SG, Dorsey G, Pullan RL. Kigozi SP, et al. Among authors: kigozi rn. Am J Trop Med Hyg. 2020 Jul;103(1):404-414. doi: 10.4269/ajtmh.19-0950. Epub 2020 Apr 2. Am J Trop Med Hyg. 2020. PMID: 32274990 Free PMC article.
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.
Ebong C, Sserwanga A, Namuganga JF, Kapisi J, Mpimbaza A, Gonahasa S, Asua V, Gudoi S, Kigozi R, Tibenderana J, Bwanika JB, Bosco A, Rubahika D, Kyabayinze D, Opigo J, Rutazana D, Sebikaari G, Belay K, Niang M, Halsey ES, Moriarty LF, Lucchi NW, Souza SSS, Nsobya SL, Kamya MR, Yeka A. Ebong C, et al. Among authors: kigozi r. Malar J. 2021 Dec 24;20(1):484. doi: 10.1186/s12936-021-04021-5. Malar J. 2021. PMID: 34952573 Free PMC article.
Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.
Yeka A, Kigozi R, Conrad MD, Lugemwa M, Okui P, Katureebe C, Belay K, Kapella BK, Chang MA, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ. Yeka A, et al. Among authors: kigozi r. J Infect Dis. 2016 Apr 1;213(7):1134-42. doi: 10.1093/infdis/jiv551. Epub 2015 Nov 23. J Infect Dis. 2016. PMID: 26597254 Free PMC article. Clinical Trial.
28 results